← Leaderboards
Claudia A Chiriboga
Columbia University Health Sciences
$5,375,833
Attributed
$8,426,862
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $469.3K · FY2011–25$500K$375K$250K$125K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,426,862 · 3
By mechanism
R01$3,299,244 · 1
U24$2,923,323 · 1
U10$2,204,295 · 1
Top collaborators
- Karen S Marder15 shared
- Susan A Gauthier3 shared
- Harini Sarva3 shared
- Claire Henchcliffe2 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Karen S Marder$15,291,810
- Yaakov Stern$60,326,200
- Ralph Lewis Sacco$56,271,933
- Willard Allen Hauser$3,055,238
- Suzanne Bakken$19,982,764
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchParticipantAdvocateMedical SchoolsNeurosurgeryNeurosciencesEnrollmentMedical CenterFamilyDesignHospitalsFacultyNational Institute Of Neurological Disorders And StrokeNervous System DisorderMethodologyConduct Clinical TrialsFoundationsCollaborationsAdultNew YorkClinical TrialsChildhoodAcademic Medical CentersPresbyterian Church
Grant awards (20)
Clinical Research Sites for the Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT sites) (U24 Clinical Trial Not Allowed)$439,931
U24 · FY2025 · NS
Clinical Research Sites for the Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT sites) (U24 Clinical Trial Not Allowed)$433,251
U24 · FY2024 · NS
Clinical Research Sites for the Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT sites) (U24 Clinical Trial Not Allowed)$469,300
U24 · FY2023 · NS
Clinical Research Sites for the Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT sites) (U24)$301,140
U24 · FY2022 · NS
Clinical Research Sites for the Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT sites) (U24)$306,816
U24 · FY2021 · NS
Clinical Research Sites for the Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT sites) (U24)$313,296
U24 · FY2020 · NS
Clinical Research Sites for the Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT sites) (U24)$322,574
U24 · FY2019 · NS
Clinical Research Sites for the Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT sites) (U24)$337,015
U24 · FY2018 · NS
Columbia University Medical Center - Weill Cornell Medical Center NEXT Site$320,817
U10 · FY2017 · NS
Columbia University Medical Center - Weill Cornell Medical Center NEXT Site$320,817
U10 · FY2016 · NS
Columbia University Medical Center - Weill Cornell Medical Center NEXT Site$320,817
U10 · FY2015 · NS
Columbia University Medical Center - Weill Cornell Medical Center NEXT Site$274,220
U10 · FY2014 · NS
Columbia University Medical Center - Weill Cornell Medical Center NEXT Site$314,325
U10 · FY2013 · NS
Columbia University Medical Center - Weill Cornell Medical Center NEXT Site$323,465
U10 · FY2012 · NS
Columbia University Medical Center - Weill Cornell Medical Center NEXT Site$329,834
U10 · FY2011 · NS
QUANTIFIED FETAL COCAINE EXPOSURE AND NEURODEVELOPMENT$499,122
R01 · FY2004 · DA
QUANTIFIED FETAL COCAINE EXPOSURE AND NEURODEVELOPMENT$682,428
R01 · FY2003 · DA
QUANTIFIED FETAL COCAINE EXPOSURE AND NEURODEVELOPMENT$772,626
R01 · FY2002 · DA
QUANTIFIED FETAL COCAINE EXPOSURE AND NEURODEVELOPMENT$733,360
R01 · FY2001 · DA
QUANTIFIED FETAL COCAINE EXPOSURE AND NEURODEVELOPMENT$611,708
R01 · FY2000 · DA